基本信息
浏览量:2
职业迁徙
个人简介
Dr. Rich has a career interest in understanding the causes and treatments of pulmonary hypertension. He was principle investigator for the NIH Registry on Primary Pulmonary Hypertension, the first of its kind, and has been the leader of the largest clinical center in the USA for evaluating and treating patients with pulmonary hypertension since 1980. Dr. Rich has conducted pioneering research on the molecular mechanisms, epidemiology, clinical presentation, natural history and treatments of the disease. This knowledge has lead to the discovery of more effective treatments for pulmonary hypertension, including the use of medicines like anticoagulants, calcium channel blockers, and prostacyclins. His pioneering research has led to a greater understanding of all types of pulmonary hypertension.
研究兴趣
论文共 327 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Circulation. Heart failureno. 4 (2024): e011095-e011095
European journal of heart failure (2024)
M. Girardis,D. Bettex, M. Bojan, C. Demponeras, S. Fruhwald, J. Gál, H. V. Groesdonk, F. Guarracino, J. L. Guerrero-Orriach, M. Heringlake,A. Herpain, L. Heunks,
Journal of Anesthesia, Analgesia and Critical Careno. 1 (2022): 1-22
Journal of the American College of Cardiologyno. 18 (2022): 1858-1869
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn